With increasing sponsor and regulatory demand for tailored laboratory solutions in clinical research, the development and validation of novel diagnostic assays has become essential. To support these requirements, Dr. Dangs Central Lab undertakes structured validation processes that enable the reliable implementation of niche and esoteric assays for use in sponsored clinical studies.
Validation of test parameters is performed through a comprehensive assessment of key performance characteristics, including sensitivity, specificity, precision, and reproducibility. These evaluations establish assay credibility and ensure consistent, dependable performance aligned with study objectives and regulatory expectations.
To date, Dr. Dangs Lab has successfully validated more than 70 test parameters across a broad range of esoteric assays, including immunogenicity markers and other specialized tests performed on ELISA- and flow cytometry–based platforms. These validation capabilities underpin the laboratory's commitment to delivering high-quality, reliable diagnostics for complex and evolving clinical research programs.
